|
Supplier News Breaks Archives ECRM has launched a series of reports and a blog that examine retail circular advertising. Endo Pharmaceuticals has obtained Food and Drug Administration clearance to market Fortesta Gel for topical use to treat men with low testosterone. Impax Laboratories Inc. has received final approval from the Food and Drug Administration for 75-mg and 100-mg doxycyline hyclate delayed-release tablets, a generic version of the antibacterial medication Doryx. Frito-Lay North America plans to make about 50% of its product portfolio with all-natural ingredients and has begun shipping the first natural snacks to retailers. Coty Inc. is launching a wide range of Sally Hansen beauty implements and nail care products in the first quarter, including polish, polish strips, gel treatments and growth serum. Nice-Pak Products Inc. has transformed its Mooresville, Ind., manufacturing plant into what it calls a “zero landfill” facility. Cephalon Inc. has appointed J. Kevin Buchi as chief executive officer and a member of the biopharmaceutical company's board. Gardasil, Merck's vaccine for human papillomavirus (HPV), has been approved by the Food and Drug Administration for the prevention of anal cancer and anal intraepithelial neoplasia (AIN).
|
